期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

化疗致乙肝病毒再激活研究进展 被引量：3

下载PDF
导出
摘要 全世界超过1／3人感染过乙型肝炎病毒，保守估计，约有3．5亿的携带者，其中75％人生活在东南亚和西太平洋地区，超过8％人为慢性携带者。
作者 陈彦帆 韦燕
机构地区 广西省贵港市人民医院肿瘤科
出处 《肿瘤预防与治疗》 2011年第4期192-195,共4页 Journal of Cancer Control And Treatment
关键词 肿瘤 乙肝病毒 化疗
分类号 R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Winnie Yeo, Paul KS Chan, Wing M Ho, et al. Lamivudine for the prevention of hepatitis B vires reactivation in hepatitis B s-anti- gen seropositive cancer patients undergoing cytotoxic chemotherapy [ J]. Journal of Clinical Oncology ,2004,22 (5) :927-934.
  • 2黄正京,周脉耕,王黎君.中国肝癌死亡率和乙肝病毒表面抗原携带率的地理分布研究[J].疾病监测,2007,22(4):242-245. 被引量：42
  • 3Yeo W, Chart PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors [J]. J Med Virol,2000,62(3) :299-307.
  • 4Xunrong L, Yan AW, Liang R, et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy-pathagen- esis and management [ J ]. Rev Med Virol, 2001,11 ( 5 ) : 287- 299.
  • 5Yeo W, Johnson PJ. Prevention and management of hepatitis B virus reactivation during anticancer therapy [ J]. Hepatology, 2006, 43 (2) :209-220.
  • 6马振华,刘元元,牛俊奇,王峰.乙型肝炎患者治疗过程中宿主的免疫应答[J].哈尔滨医科大学学报,2010,44(1):33-36. 被引量：2
  • 7Cil T,Altintas A, Pasa S, et al. Lanilvudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen ( HB- SAG) serepositive cancer patients undergoing cytotoxic chemotherapy[J]. Leuk lymphoma,2008,49(5) :939-947.
  • 8梁晨,姜尔烈,黄勇,阎嶂松,杨栋林,何袆,马巧玲,魏嘉璘,王玫,冯四洲,邱录贵,韩明哲.供受者乙型肝炎病毒感染对造血干细胞移植后受者临床影响的研究[J].中华血液学杂志,2010,31(7):456-460. 被引量：9
  • 9George K. K. Lau, Yu-hung Leung, Daniel Y. T. Fong, et al. High hepatitis B virus (HBV) DNA viral load as the most impor- tant risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplan- tation[J]. Blood, 2002,99(7) :2324-2330.
  • 10Koo YX, Tan DS, Tan BH, et al. Risk of hepatitis B virus reacti- vation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral rophylaxis [ J ]. Journal of Clinical Oncology, 2009, 27 (15) :2570-2571.

二级参考文献70

共引文献93

同被引文献40

  • 1贾继东.免疫抑制治疗与乙型肝炎病毒再激活[J].中华内科杂志,2006,45(6):443-444. 被引量：32
  • 2罗生强,张玲霞.2007年美国慢性乙型肝炎诊治推荐意见简介[J].中华肝脏病杂志,2007,15(6):477-480. 被引量：58
  • 3JH, Choi WH, Han E J, et aL The Prognostic Value of <sup>18</sup>F-FDG PET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage [J].Nucl Med Mol Imaging,2013,47(4):263 -267.
  • 4Lechner J, von Baehr V. Hyperactivated Signaling Pathways of Chemokine RANTES/CCL5 in Osteopathies of Jawbone in Breast Cancer Patients-Case Report and Research[J]. Breast Cancer (Auckl), 2014, 8:89-96.
  • 5Xu P, Yu H, Zhang Z, et al. Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis[J]. Biomaterials, 2014, 35(26): 7574-7578.
  • 6Xu L, Tu Z, Xu G, et al. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable I-lBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy [J]. Mol Med Rep, 2014, 9(4): 1345-1350.
  • 7Zheng Y, Zhang S, Tan Grahn HM, et al. Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis[J]. Hepat Mort, 2013, 13(4): e6496.
  • 8Lee HJ, Kim DY, Keam B, et al. Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy[J]. Breast Cancer, 2014, 21(4): 387-393.
  • 9Nishimura Y, Ishii J, Okazaki F, et al. Complex carders of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery[J]. J Drug Target, 2012, 20(10): 897-905.
  • 10Liu Y, Tong Z, Li T, et al. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promot human hepatocellular carcinoma cell invasiveness [J]. Hepatology, 2012, 56(3): 1015-1024.

引证文献3

二级引证文献10

肿瘤预防与治疗
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部